Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, No. 49 North Hua Yuan Road, Hai Dian District, Beijing 100191, China.
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproduction, Beijing 100191, China.
ACS Appl Mater Interfaces. 2020 Apr 22;12(16):18352-18362. doi: 10.1021/acsami.0c02719. Epub 2020 Apr 13.
Various types of cells are routinely cryopreserved in modern regenerative and cell-based medicines. For instance, the oocyte is one of the most demanding cells to be cryopreserved in genetic engineering and human-assisted reproductive technology (ART). However, the usage of cryopreserved oocytes in ART clinics is still limited mainly because of the unstable survival rate. This is due to the fact that oocytes are more prone to be damaged by ice crystals in comparison to other cells, as oocytes are larger in size and surface area. Meanwhile, oocytes contain more water, and thus, ice crystals are easier to form inside the cells. Currently, to avoid injury by the formed ice crystals, cryopreservation (CP) of oocytes has to use large amounts of small molecules as cryoprotectants such as dimethyl sulfoxide (DMSO) and ethylene glycol (EG), which can permeate into the cell and prevent ice formation inside. However, these molecules are chemically and epigenetically toxic to cells. Therefore, great efforts have been focused on reducing the amount of DMSO and EG used for oocyte CP. In nature, the antifreeze (glyco)proteins (AFGPs) locate extracellularly with the ability to protect living organisms from freezing damage controlling ice growth. Inspired by this, biocompatible and nontoxic L-proline oligomers (L-Pro), which have the same polyproline II helix structure as that of AFGPs, are first employed for the CP of oocytes. The experimental results reveal that L-Pro has a profound activity in inhibiting ice growth as that of AFGP8. Also, by the addition of 50 mM L-Pro, the amount of DMSO and EG can be greatly reduced by . 1.8 M for oocyte CP; moreover, the survival rate of the cryopreserved oocytes is increased up to 99.11%, and the coefficient of variance of the survival rate is decreased from 7.47 to 2.15%. These results mean that almost all oocytes can survive after CP with our method; importantly, the mitochondrial function as a critical criterion for the quality of the frozen-thawed oocytes is also improved. It is proposed that with the addition of L-Pro, the extracellular ice growth is slowed down, which prevents the direct injuries of cells by large ice crystals and the accompanying osmotic pressure increase. As such, this work is not only significant for meeting the ever-increasing demand by the ART clinics but also gives guidance for designing materials in controlling ice growth during CP of other cells and tissues.
各种类型的细胞在现代再生医学和基于细胞的医学中经常被冷冻保存。例如,卵母细胞是基因工程和人类辅助生殖技术 (ART) 中最需要冷冻保存的细胞之一。然而,冷冻保存的卵母细胞在 ART 临床中的应用仍然受到限制,主要是因为存活率不稳定。这是因为与其他细胞相比,卵母细胞更容易受到冰晶的损伤,因为卵母细胞体积更大,表面积更大。同时,卵母细胞含有更多的水分,因此冰晶更容易在细胞内形成。目前,为了避免冰晶形成造成的损伤,卵母细胞的冷冻保存 (CP) 必须使用大量的小分子作为冷冻保护剂,如二甲基亚砜 (DMSO) 和乙二醇 (EG),这些小分子可以渗透到细胞内,防止冰晶在细胞内形成。然而,这些分子对细胞具有化学和表观遗传毒性。因此,人们致力于减少用于卵母细胞 CP 的 DMSO 和 EG 用量。在自然界中,抗冻 (糖) 蛋白 (AFGPs) 位于细胞外,具有保护生物免受冻害的能力,控制冰晶的生长。受此启发,首先将生物相容性和无毒的 L-脯氨酸低聚物 (L-Pro) 用于卵母细胞的 CP,L-Pro 具有与 AFGP8 相同的聚脯氨酸 II 螺旋结构。实验结果表明,L-Pro 具有抑制冰晶生长的活性,与 AFGP8 相当。此外,通过添加 50mM 的 L-Pro,可以将卵母细胞 CP 中 DMSO 和 EG 的用量减少 1.8M;此外,冷冻保存的卵母细胞的存活率提高到 99.11%,存活率的变异系数从 7.47 降低到 2.15%。这些结果意味着,用我们的方法进行 CP 后,几乎所有的卵母细胞都可以存活;重要的是,作为冷冻解冻卵母细胞质量关键标准的线粒体功能也得到了改善。有人提出,加入 L-Pro 后,细胞外冰晶的生长速度减慢,从而防止大冰晶直接损伤细胞,并伴随着渗透压的增加。因此,这项工作不仅对满足日益增长的 ART 临床需求具有重要意义,而且为设计其他细胞和组织 CP 过程中控制冰晶生长的材料提供了指导。